To include your compound in the COVID-19 Resource Center, submit it here.

Cancer Research UK begins Phase I of Lilly's CDC7 inihibitor in solid tumors

Cancer Research UK (London, U.K.) began a Phase I trial of LY3143921

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE